Clinic
Cambridge Public Health Commission
Cambridge Public Health Commission was paid $19.72M by Medicaid between Jan 2018 and Dec 2024, across 209 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoCAMBRIDGE PUBLIC HEALTH COMMISSION
CAMBRIDGE, MA 02139
CAMBRIDGE, MA 02139
33aNPI1306908405assigned 12/14/2006
33bProvider typeClinic/Center
28Total paid$19.72M
24GClaims543,480
24DCodes billed209
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Massachusetts
Rank by total paid#9 of 53
Median peer was paid$154K
This provider vs. median128×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,061 | $3.88M | |
| 2019 | 84,316 | $3.63M | |
| 2020 | 42,449 | $2.01M | |
| 2021 | 73,727 | $2.97M | |
| 2022 | 87,837 | $3.58M | |
| 2023 | 88,028 | $2.21M | |
| 2024incomplete | 79,062 | $1.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 49,071 | 43,340 | $5.41M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 38,969 | 35,536 | $4.04M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.3% | 27,748 | 21,870 | $854K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.8% | 2,555 | 2,100 | $555K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 4,345 | 4,111 | $446K |
| D9450 | 2.1% | 39,069 | 23,134 | $422K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 4,080 | 4,079 | $357K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.7% | 3,570 | 3,234 | $345K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 1,278 | 1,278 | $331K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 3,436 | 3,434 | $323K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 3,427 | 3,427 | $306K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 3,124 | 2,818 | $285K |
197 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 3,365 | $278K |
| D1110 | Prophylaxis - adult | 1.2% | 10,581 | $242K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 4,014 | $216K |
| 99284 | Emergency room visit (serious) | <1% | 1,032 | $193K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,233 | $184K |
| 90686 | <1% | 9,881 | $175K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 7,722 | $172K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 7,721 | $169K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,848 | $152K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 27,820 | $142K |
| D9110 | <1% | 6,044 | $134K | |
| 99285 | Emergency room visit (most serious) | <1% | 592 | $131K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 5,066 | $120K |
| D2740 | Crown - porcelain/ceramic | <1% | 596 | $117K |
| 97803 | <1% | 1,889 | $114K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 5,271 | $110K |
| 90651 | <1% | 609 | $110K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 3,349 | $103K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 264 | $102K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,317 | $100K |
| 91322 | <1% | 1,308 | $99K | |
| D0274 | Bitewings - four radiographic images | <1% | 6,129 | $99K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,401 | $98K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,728 | $94K |
| 86480 | <1% | 2,201 | $89K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,702 | $85K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 10,574 | $81K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 3,050 | $81K |
| D0120 | Dental checkup, returning patient | <1% | 7,043 | $79K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,789 | $78K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 416 | $76K |
| 97802 | <1% | 1,183 | $75K | |
| 92588 | <1% | 295 | $69K | |
| 92558 | <1% | 2,143 | $67K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,313 | $67K |
| 90715 | <1% | 2,940 | $54K | |
| 86803 | <1% | 6,803 | $53K | |
| D1120 | Dental cleaning, child | <1% | 1,064 | $50K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,279 | $49K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,606 | $47K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 694 | $46K |
| 81513 | <1% | 518 | $45K | |
| 90480 | <1% | 1,680 | $45K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 2,399 | $45K |
| D2751 | Crown - porcelain fused to predominantly base metal | <1% | 312 | $43K |
| 90750 | <1% | 1,153 | $41K | |
| 87481 | <1% | 1,385 | $40K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,195 | $39K |
| 88142 | <1% | 3,968 | $39K | |
| 85027 | <1% | 10,718 | $39K | |
| 0124A | <1% | 1,362 | $38K | |
| 80061 | Lipid panel | <1% | 10,699 | $38K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,863 | $38K |
| 90677 | <1% | 881 | $30K | |
| D2330 | <1% | 1,047 | $28K | |
| 99385 | <1% | 826 | $28K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 185 | $27K |
| 82728 | <1% | 3,455 | $27K | |
| 86780 | <1% | 3,148 | $27K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,350 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,593 | $23K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 906 | $22K |
| 90670 | <1% | 521 | $21K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,225 | $21K |
| 82607 | <1% | 2,894 | $21K | |
| D2331 | <1% | 554 | $20K | |
| 87340 | <1% | 3,113 | $18K | |
| 81025 | <1% | 3,493 | $18K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 39 | $18K |
| 81514 | <1% | 340 | $18K | |
| D2950 | <1% | 350 | $18K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 139 | $17K |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 517 | $17K |
| 80050 | General health panel | <1% | 709 | $17K |
| 83655 | <1% | 1,336 | $17K | |
| D1206 | Topical application of fluoride varnish | <1% | 671 | $16K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 9,195 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,317 | $15K |
| 90656 | <1% | 1,009 | $15K | |
| 86706 | <1% | 2,575 | $14K | |
| 90734 | <1% | 332 | $14K | |
| 82274 | <1% | 1,303 | $13K | |
| 0054A | <1% | 396 | $12K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 129 | $12K |
| 90662 | <1% | 1,587 | $12K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,861 | $11K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 117 | $11K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 348 | $11K |
| 82043 | <1% | 4,283 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,545 | $10K |
| D0330 | Panoramic radiographic image | <1% | 331 | $10K |
| 87070 | <1% | 1,271 | $10K | |
| D2140 | <1% | 406 | $10K | |
| 82570 | <1% | 4,434 | $10K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 425 | $8K |
| 81003 | <1% | 4,389 | $8K | |
| 83037 | <1% | 4,619 | $8K | |
| ATP14 | <1% | 892 | $7K | |
| 90746 | <1% | 342 | $7K | |
| 87660 | <1% | 313 | $7K | |
| 87510 | <1% | 313 | $7K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 101 | $7K |
| 90633 | <1% | 283 | $6K | |
| 86592 | <1% | 1,974 | $6K | |
| 80076 | <1% | 2,198 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 853 | $6K |
| 87480 | <1% | 313 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,064 | $6K |
| 99386 | <1% | 167 | $6K | |
| 82948 | <1% | 3,215 | $6K | |
| 83540 | <1% | 1,686 | $5K | |
| ATP08 | <1% | 832 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 87 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 114 | $5K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 156 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 171 | $4K |
| D1351 | Sealant - per tooth | <1% | 149 | $4K |
| 84153 | <1% | 782 | $4K | |
| 90680 | <1% | 318 | $4K | |
| D5212 | <1% | 12 | $4K | |
| 90714 | <1% | 250 | $4K | |
| 86762 | <1% | 479 | $4K | |
| 86704 | <1% | 829 | $3K | |
| D0272 | Bitewings - two radiographic images | <1% | 158 | $3K |
| 83550 | <1% | 710 | $3K | |
| 85018 | <1% | 1,379 | $3K | |
| 81001 | <1% | 1,434 | $3K | |
| 90685 | <1% | 252 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 57 | $3K |
| D5211 | <1% | 12 | $3K | |
| 86787 | <1% | 435 | $3K | |
| 90732 | <1% | 294 | $3K | |
| 86850 | <1% | 189 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 29 | $3K |
| 84439 | <1% | 624 | $3K | |
| 90739 | <1% | 217 | $3K | |
| 83735 | <1% | 414 | $3K | |
| 86708 | <1% | 571 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 50 | $2K |
| 87338 | <1% | 221 | $2K | |
| 90707 | <1% | 86 | $2K | |
| 90716 | <1% | 54 | $2K | |
| 86901 | <1% | 191 | $2K | |
| D2335 | <1% | 21 | $2K | |
| 86900 | <1% | 191 | $2K | |
| 83718 | <1% | 369 | $2K | |
| 83721 | <1% | 203 | $1K | |
| 0004A | <1% | 49 | $1K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 14 | $1K |
| 86765 | <1% | 262 | $1K | |
| 83690 | <1% | 191 | $1K | |
| 90474 | <1% | 1,619 | $1K | |
| 87186 | <1% | 162 | $1K | |
| 84702 | <1% | 74 | $1K | |
| 90710 | <1% | 36 | $1K | |
| 86735 | <1% | 238 | $1K | |
| 86682 | <1% | 113 | $940.54 | |
| 90688 | <1% | 34 | $881.38 | |
| 82950 | <1% | 181 | $866.12 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 931 | $858.92 |
| ATP03 | <1% | 937 | $830.44 | |
| D0270 | <1% | 154 | $689.00 | |
| 85610 | <1% | 337 | $679.78 | |
| 90696 | <1% | 34 | $587.22 | |
| 90473 | <1% | 77 | $574.92 | |
| D2160 | <1% | 22 | $573.00 | |
| 87077 | <1% | 106 | $570.06 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 49 | $534.49 |
| D0180 | <1% | 22 | $412.00 | |
| 84450 | <1% | 125 | $390.05 | |
| 90632 | <1% | 13 | $343.22 | |
| 84460 | <1% | 158 | $279.73 | |
| 86140 | <1% | 108 | $262.59 | |
| 83026 | <1% | 90 | $251.70 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 33 | $238.78 |
| 82465 | <1% | 292 | $235.10 | |
| 84703 | <1% | 28 | $233.80 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,729 | $199.43 |
| 82746 | <1% | 28 | $181.58 | |
| 0121A | <1% | 15 | $175.52 | |
| 85651 | <1% | 57 | $154.81 | |
| 99401 | <1% | 67 | $113.32 | |
| ATP17 | <1% | 14 | $100.08 | |
| 99188 | <1% | 57 | $86.48 | |
| 91312 | <1% | 627 | $0.02 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 44 | $0.00 |
| 36416 | 0% | 163 | $0.00 | |
| 90723 | 0% | 333 | $0.00 | |
| D9995 | 0% | 72 | $0.00 | |
| D2750 | 0% | 133 | $0.00 | |
| 91305 | 0% | 165 | $0.00 | |
| D4342 | 0% | 64 | $0.00 | |
| 90648 | 0% | 469 | $0.00 | |
| D4341 | 0% | 861 | $0.00 | |
| 91300 | 0% | 52 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 99397 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEEFE, DENNIS (CEO)
| Provider | Location | Paid |
|---|---|---|
| Cambridge Public Health Commission | Cambridge, MA | $809K |
| Cambridge Public Health Commission | Cambridge, MA | $204K |
| Cambridge Public Health Commission | Cambridge, MA | $188K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.